List of Excipients in API HYDROCORTISONE ACETATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing HYDROCORTISONE ACETATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | CETYL ALCOHOL | |
| Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | ETHYLENE DISTEARAMIDE | |
| Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | ISOBUTANE | |
| Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | METHYLPARABEN | |
| Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | PROPANE | |
| Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | PROPYLENE GLYCOL | |
| Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | PROPYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing HYDROCORTISONE ACETATE
Detailed excipient profiles for HYDROCORTISONE ACETATE
Excipient focus: BENZYL CHLORIDE
HYDROCORTISONE ACETATE drug variants containing BENZYL CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Crown Laboratories | hydrocortisone acetate | 0316-0140 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing BENZYL CHLORIDE
Excipient focus: BUTYLPARABEN
HYDROCORTISONE ACETATE drug variants containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing BUTYLPARABEN
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
HYDROCORTISONE ACETATE drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Excipient focus: CETETH-20
HYDROCORTISONE ACETATE drug variants containing CETETH-20
| Company | Ingredient | NDC |
|---|---|---|
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing CETETH-20
Excipient focus: CETOSTEARYL ALCOHOL
HYDROCORTISONE ACETATE drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing CETOSTEARYL ALCOHOL
Excipient focus: CETYL ALCOHOL
HYDROCORTISONE ACETATE drug variants containing CETYL ALCOHOL
HYDROCORTISONE ACETATE drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Crown Laboratories | hydrocortisone acetate | 0316-0140 |
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID
HYDROCORTISONE ACETATE drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing CITRIC ACID
Excipient focus: DIISOPROPYL ADIPATE
HYDROCORTISONE ACETATE drug variants containing DIISOPROPYL ADIPATE
HYDROCORTISONE ACETATE drug variants not containing DIISOPROPYL ADIPATE
Excipient focus: DIMETHICONE
HYDROCORTISONE ACETATE drug variants containing DIMETHICONE
HYDROCORTISONE ACETATE drug variants not containing DIMETHICONE
Excipient focus: EDETATE DISODIUM
HYDROCORTISONE ACETATE drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing EDETATE DISODIUM
Excipient focus: ETHYLENE DISTEARAMIDE
HYDROCORTISONE ACETATE drug variants containing ETHYLENE DISTEARAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing ETHYLENE DISTEARAMIDE
Excipient focus: GLYCERIN
HYDROCORTISONE ACETATE drug variants containing GLYCERIN
HYDROCORTISONE ACETATE drug variants not containing GLYCERIN
Excipient focus: HYDROGENATED COCONUT OIL
HYDROCORTISONE ACETATE drug variants containing HYDROGENATED COCONUT OIL
HYDROCORTISONE ACETATE drug variants not containing HYDROGENATED COCONUT OIL
Excipient focus: ISOBUTANE
HYDROCORTISONE ACETATE drug variants containing ISOBUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing ISOBUTANE
Excipient focus: ISOPROPYL ALCOHOL
HYDROCORTISONE ACETATE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Crown Laboratories | hydrocortisone acetate | 0316-0140 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: ISOPROPYL MYRISTATE
HYDROCORTISONE ACETATE drug variants containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing ISOPROPYL MYRISTATE
Excipient focus: ISOPROPYL PALMITATE
HYDROCORTISONE ACETATE drug variants containing ISOPROPYL PALMITATE
HYDROCORTISONE ACETATE drug variants not containing ISOPROPYL PALMITATE
Excipient focus: LANOLIN
HYDROCORTISONE ACETATE drug variants containing LANOLIN
HYDROCORTISONE ACETATE drug variants not containing LANOLIN
Excipient focus: LIGHT MINERAL OIL
HYDROCORTISONE ACETATE drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing LIGHT MINERAL OIL
Excipient focus: METHYLPARABEN
HYDROCORTISONE ACETATE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing METHYLPARABEN
Excipient focus: PETROLATUM
HYDROCORTISONE ACETATE drug variants containing PETROLATUM
HYDROCORTISONE ACETATE drug variants not containing PETROLATUM
Excipient focus: POLYOXYL 40 STEARATE
HYDROCORTISONE ACETATE drug variants containing POLYOXYL 40 STEARATE
HYDROCORTISONE ACETATE drug variants not containing POLYOXYL 40 STEARATE
Excipient focus: POTASSIUM SORBATE
HYDROCORTISONE ACETATE drug variants containing POTASSIUM SORBATE
HYDROCORTISONE ACETATE drug variants not containing POTASSIUM SORBATE
Excipient focus: POVIDONE
HYDROCORTISONE ACETATE drug variants containing POVIDONE
HYDROCORTISONE ACETATE drug variants not containing POVIDONE
Excipient focus: PROPANE
HYDROCORTISONE ACETATE drug variants containing PROPANE
| Company | Ingredient | NDC |
|---|---|---|
| Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
| Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing PROPANE
Excipient focus: PROPYLENE GLYCOL
HYDROCORTISONE ACETATE drug variants containing PROPYLENE GLYCOL
HYDROCORTISONE ACETATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
HYDROCORTISONE ACETATE drug variants containing PROPYLPARABEN
HYDROCORTISONE ACETATE drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CITRATE
HYDROCORTISONE ACETATE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM METABISULFITE
HYDROCORTISONE ACETATE drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing SODIUM METABISULFITE
Excipient focus: SORBIC ACID
HYDROCORTISONE ACETATE drug variants containing SORBIC ACID
HYDROCORTISONE ACETATE drug variants not containing SORBIC ACID
Excipient focus: SORBITAN MONOLAURATE
HYDROCORTISONE ACETATE drug variants containing SORBITAN MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| Crown Laboratories | hydrocortisone acetate | 0316-0140 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing SORBITAN MONOLAURATE
Excipient focus: SORBITAN SESQUIOLEATE
HYDROCORTISONE ACETATE drug variants containing SORBITAN SESQUIOLEATE
HYDROCORTISONE ACETATE drug variants not containing SORBITAN SESQUIOLEATE
Excipient focus: STEARETH-10
HYDROCORTISONE ACETATE drug variants containing STEARETH-10
| Company | Ingredient | NDC |
|---|---|---|
| Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing STEARETH-10
Excipient focus: STEARIC ACID
HYDROCORTISONE ACETATE drug variants containing STEARIC ACID
HYDROCORTISONE ACETATE drug variants not containing STEARIC ACID
Excipient focus: STEARYL ALCOHOL
HYDROCORTISONE ACETATE drug variants containing STEARYL ALCOHOL
HYDROCORTISONE ACETATE drug variants not containing STEARYL ALCOHOL
Excipient focus: TRIETHANOLAMINE LAURYL SULFATE
HYDROCORTISONE ACETATE drug variants containing TRIETHANOLAMINE LAURYL SULFATE
HYDROCORTISONE ACETATE drug variants not containing TRIETHANOLAMINE LAURYL SULFATE
Excipient focus: TROLAMINE
HYDROCORTISONE ACETATE drug variants containing TROLAMINE
HYDROCORTISONE ACETATE drug variants not containing TROLAMINE
Excipient focus: UREA
HYDROCORTISONE ACETATE drug variants containing UREA
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing UREA
Excipient focus: WATER
HYDROCORTISONE ACETATE drug variants containing WATER
HYDROCORTISONE ACETATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
HYDROCORTISONE ACETATE drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Allegis Holdings LLC | hydrocortisone acetate cream | 71297-241 |
| Legacy Pharma USA Inc | hydrocortisone acetate cream | 83107-026 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing WHITE PETROLATUM
Excipient focus: XANTHAN GUM
HYDROCORTISONE ACETATE drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE ACETATE drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links